Adventus Ventures Medical Device Incubator

Adventus ventures finances medical device portfolio companies

Adventus Ventures, LLC is a venture capital company focused on medical device startups. Adventus Ventures, an incubator of medical device companies, recently announced that it has completed the first round of financing for several medical device portfolio companies.

Adventus Ventures announces initial financing for several of its medical device portfolio companies

These companies include:

• Allevion Therapeutics – Developing wearable non-invasive multi-modal smart energy-based system for treating essential tremor with continuous tremor monitoring adaptive sensor resulting in faster therapy time.
• Pressão Medical – Smart non-invasive wrist wearable device to treat millions of people at risk for stroke or heart attack due to pre-hypertension.
• Temari Medical – Developing the next generation cerebral aneurysm embolic protection system providing better treatment options.
• ZED Medical – Developing the next generation intra-body imaging and tracking to guide a variety of minimally invasive catheter-based interventions.

“We are excited to be working with outstanding and talented entrepreneurs to develop new medical device companies,” – Shawn Moaddeb, Founder & Chairman at Adventus Ventures

Allevion Therapeutics

Developing wearable non-invasive multi-modal smart energy-based system for treating essential tremor with continuous tremor monitoring adaptive sensor resulting in faster therapy time.

Pressao Medical

Smart non-invasive wrist wearable device to treat millions of people at risk for stroke or heart attack due to pre-hypertension.

ZED Medical

Developing the next generation intra-body imaging and tracking to guide a variety of minimally invasive catheter-based interventions.

“We are pleased to continue working with Adventus Ventures supporting us with initial development and strategic guidance”,
– Tom Moore, CEO of ZED Medical.

“Temari Medical’s next generation cerebral aneurysm embolic protection system has the potential to significantly address shortcomings of current devices and providing better treatment options”
– Mahmood Razavi, MD, Director of Department of Clinical Trials at St Joseph Heart & Vascular Center., and Chief Medical Officer and board member at Temari Medical.